TOPICS: Sulfonylurea, 1st generation sulfonylurea, chlorpropamide, disulfiram like reactions, tolbutamide, 2nd generation sulfonylurea, glimepiride, long acting, glyburide, glipizide, short acting, meglitinides, nateglinide, repaglinide, potassium channels, beta cells, depolarisation, insulin release, type 2 dm, hypoglycemia, renal failure, weight gain